Low-dose and high-dose ^(131)I therapy for low and intermediate risk differentiated thyroid cancer: a randomized controlled clinical study
Low-dose and high-dose ^(131)I therapy for low and intermediate risk differentiated thyroid cancer: a randomized controlled clinical study
摘要
Objective To compare the ablation efficacy and therapy response with low-dose（1.1 GBq）and high-dose（3.7 GBq） 131I in postoperative patients with low and in-termediate risk DTC.Methods A total of 140 patients（37 males,103 females,age range:18-75 years）were enrolled from October 2014 to June 2015,and
-
1吴双,杨泽,张远净,岳国军,李宁,张川骎,郭辰睿.局部晚期非小细胞肺癌诱导化疗后同期放化疗与同期放化疗疗效及安全性Meta分析[J].中华肿瘤防治杂志,2017,24(1):55-61. 被引量：10
-
2ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量：10
-
3YUYong-Li LUHan-Kui ZHURei-Sen MAJi-Xiao.^(131)I treatment for brain metastases from differentiated thyroid carcinoma[J].Nuclear Science and Techniques,2004,15(4):223-226.
-
4代佑果.Effects of tetrahydrobiopterin on the angiogenesis in hepatocellular carcinoma[J].China Medical Abstracts(Internal Medicine),2017,34(1):45-46.
-
5陈琳,张志伟,陈义发,黄志勇,朱鹏,张必翔.293例原发性肝癌术后复发的综合治疗效果分析[J].腹部外科,2017,30(2):89-92. 被引量：7
-
6Soichiro Ako,Koji Takemoto,Eriko Yasutomi,Chihiro Sakaguchi,Mayu Murakami,Tomoko Sunami,Shohei Oka,Hamada Kenta,Noriko Okazaki,Yuki Baba,Yasushi Yamasaki,Toshiyuki Asato,Daisuke Kawai,Ryuta Takenakai,Hirohumi Tsugeno,Sakiko Hiraoka,Jun Kato,Shigeatsu Fujiki.Comparing reduced-dose sodium phosphate tablets to 2L of polyethylene glycol: A randomized study[J].World Journal of Gastroenterology,2017,23(24):4454-4461. 被引量：1
